ARTICLE | Clinical News
Linzess regulatory update
September 24, 2012 7:00 AM UTC
EMA's CHMP issued a positive opinion recommending approval of Constella linaclotide from Almirall and partner Ironwood to treat moderate to severe irritable bowel syndrome with constipation (IBS-C). I...